Systems and methods for genomic annotation and distributed variant interpretation
AssigneeThe Scripps Research Institute
InventorAli Torkamani
Life of this patent
Estimating the term…
Abstract
A computer-based genomic annotation system, including a database configured to store genomic data, non-transitory memory configured to store instructions, and at least one processor coupled with the memory, the processor configured to implement the instructions in order to implement an annotation pipeline and at least one module filtering or analysis of the genomic data.
Claims31
A computer-based genomic annotation system, comprising:
- non-transitory memory configured to store instructions, and
- at least one processor coupled with the memory, the processor configured to:
- receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
- generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants;
- wherein generating the annotation file comprises:
- for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations indicates a potential functional impact of the copy number variant on at least one known gene;
- and
- populating the annotation file with the plurality of generated annotations.
A computer-based genomic annotation system, comprising:
- non-transitory memory configured to store instructions, and
- at least one processor coupled with the memory, the processor configured to:
- receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
- generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants;
- wherein generating the annotation file comprises:
- for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations indicates the amount of a previously identified copy number variant that overlaps the copy number variant;
- and
- populating the annotation file with the plurality of generated annotations.
A computer-based genomic annotation system, comprising:
- non-transitory memory configured to store instructions, and
- at least one processor coupled with the memory, the processor configured to:
- receive a variant file including a plurality of variants;
- generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants;
- wherein generating the annotation file comprises:
- for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations is an ACMG based category comprising a set of categories into which at least some variants are categorized, wherein the scoring procedure for generating the ACMG based category for a subset of the categories includes matching a subject variant with previously identified variants, evaluating the subject variant allele frequency, and evaluating predicted functional consequences of the subject variant, and wherein the scoring procedure for the subset of the categories has a sensitivity for actual disease causative variants such that no less than 98% of actual disease causative variants categorized with the scoring procedure are assigned to one of the subset of categories;
- and
- populating the annotation file with the plurality of generated annotations.
A computer-based genomic annotation system, comprising:
- non-transitory memory configured to store instructions, and
- at least one processor coupled with the memory, the processor configured to:
- receive a variant file including a plurality of variants, wherein at least one of the plurality of variants is a copy number variant;
- generate an annotation file containing annotations corresponding to a plurality of predefined annotation categories for each of the plurality of variants;
- wherein generating the annotation file comprises:
- for each variant of the plurality of variants, generating a plurality of annotations corresponding to the plurality of predefined annotation categories, wherein at least one of the plurality of generated annotations is an ACMG based category comprising a set of categories into which at least some variants are categorized, wherein the scoring procedure for generating the ACMG based category for the copy number variant comprises evaluating the amount that a previously identified copy number variant overlaps the copy number variant;
- and
- populating the annotation file with the plurality of generated annotations.
A method of testing for a genotype to phenotype association, the method comprising:
- with at least one processor, selecting a genomic region;
- with at least one processor, identifying a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype;
- and
- with at least one processor filtering the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set characterized by selected ACMG based categories;
- with at least one processor, collapsing the subset of variant sites into a collapsed set for statistical analysis;
- and
- with at least one processor, performing a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set.
A method of treating subjects with a pharmaceutical comprising:
- administering the pharmaceutical to a plurality of subjects;
- associating some of the plurality of subjects with a phenotype based at least in part on observed responses of the plurality of subjects to the pharmaceutical;
- with at least one processor, selecting a genomic region;
- with at least one processor, identifying a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype;
- and
- with at least one processor filtering the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set that are characterized by selected ACMG based categories;
- with at least one processor, collapsing the subset of variant sites into a collapsed set for statistical analysis;
- and
- with at least one processor, performing a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set;
- and
- selectively administering the pharmaceutical to the plurality of subjects and/or additional subjects based at least in part on the genotype to phenotype association.
A method of treating subjects with a pharmaceutical comprising:
- testing a subject for a defined genotype, wherein the genotype is defined at least in part by the presence or absence of at least one minor allele at a collapsed set of one or more variant sites, wherein all the variant sites of the collapsed set are associated with one or more selected ACMG based categories;
- administering the pharmaceutical to the subject if the subject exhibits the defined genotype.
A system for testing for a genotype to phenotype association, the system comprising:
- at least one processor configured to:
- select a genomic region;
- identify a set of variant sites associated with the genomic region for a plurality of subjects classified at least in part by at least one phenotype;
- and
- filter the set of variant sites to select a subset of variant sites for inclusion in a collapsed set, wherein the filtering comprises selecting variant sites from the set characterized by selected ACMG based categories;
- collapse the subset of variant sites into a collapsed set for statistical analysis;
- and
- perform a statistical test for a genotype to phenotype association in the plurality of subjects using the collapsed set.
Dependencies are inferred from the claim text.